Could your home be making your lung disease worse?
NCT ID NCT07457502
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at 100 adults with fibrosing interstitial lung diseases (a type of lung scarring) to see if things like mold, dust, air pollution, and other home factors make the disease progress faster. Researchers will compare patients whose disease is getting worse to those whose disease is stable. The goal is to better understand how the home environment affects lung health and to help patients reduce harmful exposures.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ASSESS CMEI RECOMMENDATIONS' IMPACT ON RESPIRATORY HEALTH are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Hôpital Paris Saint Joseph
RECRUITINGParis, Paris, 75014, France
-
Hôpital de Tenon
RECRUITINGParis, Paris, 75020, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a new pill slow lung scarring in IPF?
- Beyond the lungs: the hidden emotional toll of IPF medications
- Can umbilical cord stem cells ease a scarring lung disease?
- Spotting hidden blood clots in scarred lungs: a study hunts for clues
- What makes someone stop a lung fibrosis drug? a study asks patients directly
- A smarter way to track lung disease? new platform aims to personalize COPD and IPF care